Intellia Therapeutics, Inc. (NTLA)

10.38 -0.14 (-1.33%) USD  |  NASDAQ  |  Jan 09, 16:00
10.41 +0.03 (+0.29%) After-Hours: 20:00
More

Intellia Therapeutics Total Long Term Debt (Quarterly): 70.59M for Sept. 30, 2025

Total Long Term Debt (Quarterly) Chart

View Total Long Term Debt (Quarterly) for NTLA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Total Long Term Debt (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Total Long Term Debt Definition

View Total Long Term Debt Definition
Start Trial

Total Long Term Debt is the current and non-current portion of debt that a company holds. Current Portion debt are obligations of a company lasting shorter than a year. This is found in a company's current liabilities on its balance sheet.

Read full definition.

Total Long Term Debt (Quarterly) Range, Past 5 Years

View Total Long Term Debt (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Total Long Term Debt (Quarterly) Benchmarks

View Total Long Term Debt (Quarterly) Benchmarks
Start Trial
Beam Therapeutics, Inc. 138.73M
ANI Pharmaceuticals, Inc. 631.58M
Regeneron Pharmaceuticals, Inc. 2.706B
Pacific Biosciences of California, Inc. 699.46M
Twist Bioscience Corp. 61.75M